Only a recent study demonstrated that serum IGFBP2 level was elevated in gastric cancer patients (2.2-fold change) compared to age- and sex-matched healthy controls, using a quantitative proteomic approach [19]. The gene discussed is IGFBP2; the disease is gastric cancer.